Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 797.13B | 795.27B | 851.96B | 733.01B | 551.29B |
Gross Profit | 294.93B | 266.30B | 316.52B | 286.16B | 192.99B |
EBITDA | 205.29B | 190.92B | 240.55B | 230.32B | 157.62B |
Net Income | 147.56B | 133.16B | 170.59B | 155.27B | 94.01B |
Balance Sheet | |||||
Total Assets | 1.94T | 1.93T | 1.87T | 1.78T | 1.63T |
Cash, Cash Equivalents and Short-Term Investments | 606.50B | 539.08B | 529.23B | 601.22B | 586.78B |
Total Debt | 0.00 | 6.42B | 5.11B | 2.44B | 2.16B |
Total Liabilities | 197.14B | 206.84B | 245.98B | 234.09B | 189.64B |
Stockholders Equity | 1.72T | 1.71T | 1.62T | 1.54T | 1.43T |
Cash Flow | |||||
Free Cash Flow | 214.47B | 117.88B | 52.44B | 91.22B | 96.23B |
Operating Cash Flow | 255.27B | 171.76B | 99.50B | 125.58B | 118.00B |
Investing Cash Flow | -134.08B | -13.56B | -78.00B | -53.93B | -16.77B |
Financing Cash Flow | -136.62B | -122.51B | -127.92B | -89.15B | -53.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | $148.79B | 38.38 | 20.84% | 1.04% | 7.00% | 16.84% | |
77 Outperform | $92.14B | 27.76 | 27.16% | 1.14% | -0.23% | 22.41% | |
77 Outperform | $77.13B | 23.17 | 107.62% | 2.28% | -1.85% | 12.04% | |
69 Neutral | $82.62B | 35.05 | 9.82% | 1.79% | 6.49% | 24.14% | |
69 Neutral | $39.86B | 44.52 | 25.86% | 1.45% | -11.19% | -22.50% | |
63 Neutral | $24.09B | 25.27 | 8.51% | 1.32% | -5.02% | 6.69% | |
58 Neutral | HK$14.81B | 4.65 | -2.78% | 5.10% | 3.80% | -54.55% |